|
Index of reports
> Cases with Febrile Neutropenia (153)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 153 Next >>
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-21
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-17
End date: 2012-07-20
Dasatinib
Dosage: 40 milligram daily;
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-29
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-13
End date: 2012-07-21
Other drugs received by patient: Zofran; Miralax
Possible Cytarabine side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22
Patient: 54 year old female
Reactions: Osteomyelitis, Febrile Neutropenia, Osteonecrosis, Bacterial Disease Carrier, Face Oedema, Osteonecrosis of JAW, Endocarditis Enterococcal, Bone Marrow Failure, Candidiasis, Purulent Discharge, Pain in JAW
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 3 g/m2 every 12 hours for 4 days
Daunorubicin HCL
Dosage: 45 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-08-21
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 mg, 2x/day
Indication: Medulloblastoma
Cytarabine
Dosage: 50 mg, cyclic, every other month
Cytarabine
Dosage: 50 mg, cyclic, every other week then monthly
Indication: Medulloblastoma
Etoposide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-20
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13
Patient: 61 year old female
Reactions: Rash Pustular, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Diffuse Large B-Cell Lymphoma Recurrent, Rash, Sensorimotor Disorder, Skin Plaque, Mood Altered, Epidermal Necrosis, Oedema, Blister
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Methotrexate
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Etoposide; Melphalan Hydrochloride; Carmustine
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Belgium on 2012-08-10
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 45 year old male
Reported by a physician from United States on 2012-08-08
Patient: 45 year old male
Reactions: Electrocardiogram QT Prolonged, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acyclovir
Indication: Prophylaxis
Cytarabine
Dosage: 200 mg/m2, cyclic, (total dose 43.02 mg)
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-24
Cytarabine
Dosage: 200 mg/m2, cyclic, (total dose 44.46 g)
Start date: 2012-05-30
Daunorubicin HCL
Dosage: 60 mg/m2, cyclic, (total 5 courses of therapy)
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-24
Fluconazole
Indication: Prophylaxis
Piperacillin
Indication: Prophylaxis
Sprycel
Dosage: 50 mg, cyclic, (total dose 1800 mg)
Start date: 2012-03-19
Sprycel
Dosage: 100 mg, cyclic, (total dose 2100 mg)
Start date: 2012-05-30
Sprycel
Dosage: 100 mg, cyclic
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2011-12-24
Possible Cytarabine side effects in male
Reported by a physician from Belgium on 2012-08-06
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)
Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-17
End date: 2012-04-23
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-02
End date: 2012-04-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-05-06
End date: 2012-05-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Infection Prophylaxis
Start date: 2012-05-06
End date: 2012-05-08
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-05-06
End date: 2012-05-07
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-04-09
End date: 2012-04-10
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-09
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-08
End date: 2012-04-08
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-05-20
End date: 2012-05-22
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-03-29
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-06-02
End date: 2012-06-05
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-20
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-05
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-01
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-16
Imipenem and Cilastatin
Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-07
End date: 2012-05-28
Penicillin G
Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-04
End date: 2012-05-09
Vancomycin
Indication: Product Used FOR Unknown Indication
Voriconazole
Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-08
End date: 2012-05-08
Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa
Possible Cytarabine side effects in 50 year old female
Reported by a individual with unspecified qualification from Canada on 2012-07-26
Patient: 50 year old female
Reactions: Haemoptysis, Haemorrhage, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Alveolitis Allergic, Panniculitis, Colitis, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from Sweden on 2012-07-26
Patient: female, weighing 68.5 kg (150.7 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-20
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-05-19
Possible Cytarabine side effects in 59 year old female
Reported by a physician from United States on 2012-07-18
Patient: 59 year old female
Reactions: Respiratory Failure, Platelet Count Decreased, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-11
Cytarabine
Dosage: 1920 mg, cyclic
Start date: 2012-05-16
End date: 2012-05-16
Sprycel
Dosage: 600 mg, cyclic
Administration route: Oral
Start date: 2012-05-16
End date: 2012-05-26
Sprycel
Dosage: unk
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-11
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient:
Reactions: Bacteraemia, Febrile Neutropenia, Haematotoxicity
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Cytarabine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Dexamethasone
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Mabthera
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Methotrexate
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Vincristine
Indication: non-Hodgkin's Lymphoma Unspecified Histology Aggressive
Possible Cytarabine side effects in
Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13
Patient:
Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Burkitt's Lymphoma
Cytarabine
Indication: Burkitt's Lymphoma
Dexamethasone
Indication: Burkitt's Lymphoma
Doxorubicin Hydrochloride
Indication: Burkitt's Lymphoma
Etoposide
Indication: Burkitt's Lymphoma
Ifosfamide
Indication: Burkitt's Lymphoma
Mabthera
Indication: Burkitt's Lymphoma
Methotrexate
Indication: Burkitt's Lymphoma
Methylprednisolone
Indication: Prophylaxis
Prednisone
Indication: Burkitt's Lymphoma
Vincristine
Indication: Burkitt's Lymphoma
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from Netherlands on 2012-07-13
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae 05/jun/2012
Start date: 2012-06-05
Cisplatin
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Cytarabine
Dosage: last dose prior to sae 06/jun/2012
Start date: 2012-06-06
Cytarabine
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-05
Dexamethasone
Dosage: last dose prior to sae 07/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Dexamethasone
Dosage: last dose prior to sae 08/jun/2012
Start date: 2012-06-05
Mabthera
Dosage: last dose prior to sae 08/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-08
Mabthera
Dosage: last dose prior to sae 09/jun/2012
Start date: 2012-06-09
Other drugs received by patient: Augmentin '125'; Ciprofloxacin HCL; Nexium; Fungizone; Keppra; Keppra; Valganciclovir; Allopurinol
Possible Cytarabine side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10
Patient: 10 year old female
Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 300 mg/m2
Cyclophosphamide
Dosage: 250 mg/m2, bid for six doses
Indication: non-Hodgkin's Lymphoma
Cytarabine
Dosage: 100 mg/m2, daily x 5 days
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 30 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 60 mg/m2, single
Hydrocortisone Acetate
Dosage: given with methotrexate
Indication: non-Hodgkin's Lymphoma
Hydrocortisone Acetate
Dosage: given with cytarabine
Methotrexate
Dosage: 3000 mg/m2, single
Methotrexate
Dosage: given with hydrocortisone twice x 2
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1500 mg/m2, single
Prednisolone
Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
Indication: non-Hodgkin's Lymphoma
Prednisolone
Dosage: 60 mg/m2, daily for 7 days
Rituximab
Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg/m2, single
Vincristine
Dosage: 1 mg/m2, single
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Death, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Immune Globulin NOS
Indication: Pancytopenia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from Netherlands on 2012-07-05
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Cisplatin
Dosage: last dose prior to sae 05/jun/2012
Start date: 2012-06-05
Cytarabine
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-05
Cytarabine
Dosage: last dose prior to sae 06/jun/2012
Start date: 2012-06-06
Dexamethasone
Dosage: last dose prior to sae 08/jun/2012
Start date: 2012-06-05
Dexamethasone
Dosage: last dose prior to sae 07/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Mabthera
Dosage: last dose prior to sae 08/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-08
Mabthera
Dosage: last dose prior to sae 09/jun/2012
Start date: 2012-06-09
Other drugs received by patient: Ciprofloxacin HCL; Augmentin '125'; Valganciclovir; Keppra; Fungizone; Nexium; Allopurinol
Possible Cytarabine side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Singapore on 2012-07-05
Patient: 65 year old female
Reactions: Pneumonia Klebsiella, Diarrhoea, Sepsis, Chills, Febrile Neutropenia, Anal Abscess, Toxic Skin Eruption
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Other drugs received by patient: Idarubicin HCL
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02
Patient:
Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myeloid Leukaemia
Aclarubicin (Aclarubicin) Unspecified
Dosage: 10 mg, in 1 cyclical
Indication: Myelodysplastic Syndrome
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myeloid Leukaemia
Cytarabine
Dosage: 10 mg/m2, in 1 cyclical
Indication: Myelodysplastic Syndrome
Decitabine
Dosage: 15 mg/m2, in 1 cyclical, intravenous
Indication: Myeloid Leukaemia
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myelodysplastic Syndrome
Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
Indication: Myeloid Leukaemia
Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-29
Patient: 50 year old female
Reactions: Mouth Haemorrhage, Haemoptysis, Acute Myeloid Leukaemia, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1 to 7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, on days 1 and 3
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in male
Reported by a physician from Belgium on 2012-06-28
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Febrile Neutropenia, Encephalopathy, Pneumonia Cytomegaloviral, Mucosal Inflammation, Cerebral Artery Embolism, Pericarditis, Respiratory Failure, Ventricular Tachycardia, Sepsis, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Evoltra
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Floxacillin Sodium
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28
Patient: male, weighing 74.8 kg (164.6 pounds)
Reactions: Enterovesical Fistula, Oedema Peripheral, Febrile Neutropenia, Abscess
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 57.3 mg, qd, for 5 days
Start date: 2012-03-16
End date: 2012-03-20
Clolar
Dosage: 46 mg, qd for consolidation treatment
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-28
Cytarabine
Dosage: 3820 mg, qd for induction treatment, for 5 days
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-16
End date: 2012-03-20
Cytarabine
Dosage: 3600 mg, qd, for 4 days
Start date: 2012-04-28
End date: 2012-05-01
Neupogen
Dosage: 300 mcg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-15
End date: 2012-04-04
Neupogen
Dosage: 300 mcg, qd
Start date: 2012-04-28
End date: 2012-05-01
Other drugs received by patient: Nicotine; Docusate; Lorazepam; Hydrocodone Bitartrate and Acetaminophen; Ondansetron (Zofran); Omeprazole; Lorazepam; Zolpidem; Acyclovir; Senna-Mint WAF; Oxycodone HCL; Levaquin; Voriconazole
Possible Cytarabine side effects in 38 year old female
Reported by a physician from United States on 2012-06-25
Patient: 38 year old female
Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 5640 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Leucovorin Calcium
Dosage: 125 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Methotrexate Sodium
Dosage: 1880 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Methylprednisolone
Dosage: 300 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Sprycel
Dosage: 980 mg, unk
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-04-13
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from Netherlands on 2012-06-22
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Convulsion
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Cisplatin
Dosage: last dose prior to sae 05/jun/2012
Start date: 2012-06-05
Cytarabine
Dosage: last dose prior to sae 06/jun/2012
Start date: 2012-06-06
Cytarabine
Dosage: last dose prior to sae 05/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-05
Dexamethasone
Dosage: last dose prior to sae 08/jun/2012
Start date: 2012-06-05
Dexamethasone
Dosage: last dose prior to sae 07/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-04
Mabthera
Dosage: last dose prior to sae 08/may/2012
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-08
Mabthera
Dosage: last dose prior to sae 09/jun/2012
Start date: 2012-06-09
Other drugs received by patient: Keppra; Valganciclovir; Fungizone; Ciprofloxacin HCL; Depakene; Augmentin '125'; Nexium; Allopurinol
Possible Cytarabine side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-22
Patient: female, weighing 65.2 kg (143.4 pounds)
Reactions: Pneumonia, Febrile Neutropenia, Bone Marrow Failure, Escherichia Bacteraemia, Aspergillus Test Positive, Hydropneumothorax
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 40800 mg
Elspar
Dosage: 20000 mg
Page 1 Next >>
|
